Thermo Fisher Scientific is proud to announce a tremendous milestone in our journey to serve science and improve the world鈥檚 health and safety. We have successfully raised $1.4 billion in new funding, marking a pivotal moment for our company and the scientific community at large. As the global leader with annual revenues of around $40 billion, Thermo Fisher Scientific, along with our renowned brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD, has continually worked to accelerate life sciences research, address complex analytical challenges, and enhance patient health through innovations in diagnostics and therapy development. The purpose of this significant infusion of capital is to expand our research and development capabilities, further advance our innovative technologies, and broaden the array of services we offer. By investing in cutting-edge technologies and infrastructure, we aim to support labs and health organizations in making breakthrough discoveries and solving pressing challenges in real time. This funding will not only help us increase productivity in scientific laboratories around the world but also ensure that we remain at the forefront of delivering high-quality pharmaceutical services and comprehensive laboratory solutions. As we continue to drive progress in scientific research and patient care, we remain committed to our mission of making the world healthier, cleaner, and safer. We are grateful for the confidence our investors have placed in us, and we look forward to leveraging this new capital to fuel innovation, expand our global impact, and continue our leadership in serving science. For more information on Thermo Fisher Scientific and our mission, please visit www.thermofisher.com.
Thermo Fisher Scientific Secures $1.4 Billion Funding to Propel Global Scientific Innovation
Recently funded 路 $1.4BBiotechnology Research
Get the full Thermo Fisher Scientific company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
